Coronary artery bypass in patients with type 2 diabetes: Experience from the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial

Edward Y. Sako, Maria Mori Brooks, Regina M. Hardison, Hartzell V Schaff, Robert L. Frye

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objective: Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) was a study ofmanagement strategies for diabetic patients with myocardial ischemia and coronary artery disease. In a 2 × 2 design, early revascularization versus medical management with or without late revascularization and insulin sensitization versus insulin provision were examined. No advantage for either strategy was seen, except in the group undergoing early coronary artery bypass grafting (CABG). In that group, a reduction in subsequent myocardial infarction was noted. The purpose of our report was to characterize the conduct and short-term outcomes for CABG that led to this result.

Methods: Data from the BARI 2D CABG stratum were collected, including the baseline demographic and cardiovascular characteristics, technical details of the operation, and perioperative morbidity and mortality, and analyzed.

Results: A total of 347 patients were studied. The average cardiac function was normal, and most had multivessel disease. Almost all had undergone CABG by way of a median sternotomy using an internal mammary artery, and one third were off pump. The perioperative morbidity and mortality were low and compared well with larger outcomes databases.

Conclusions: BARI 2D showed that early CABG in patients with type 2 diabetes and myocardial ischemia and multivessel disease reduced the subsequent myocardial infarction rates. The present results have demonstrated that this was achieved using off-pump surgery in certain cases, standard myocardial protection, and routine use of the internal mammary artery or other arterial grafts.

Original languageEnglish (US)
Pages (from-to)1268-1272
Number of pages5
JournalJournal of Thoracic and Cardiovascular Surgery
Volume148
Issue number4
DOIs
StatePublished - Oct 1 2014

Fingerprint

Angioplasty
Coronary Artery Bypass
Type 2 Diabetes Mellitus
Mammary Arteries
Myocardial Ischemia
Myocardial Infarction
Insulin
Morbidity
Sternotomy
Mortality
Coronary Artery Disease
Demography
Databases
Transplants

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Pulmonary and Respiratory Medicine
  • Medicine(all)

Cite this

Coronary artery bypass in patients with type 2 diabetes : Experience from the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial. / Sako, Edward Y.; Brooks, Maria Mori; Hardison, Regina M.; Schaff, Hartzell V; Frye, Robert L.

In: Journal of Thoracic and Cardiovascular Surgery, Vol. 148, No. 4, 01.10.2014, p. 1268-1272.

Research output: Contribution to journalArticle

@article{3082162061a5471980dd0e8ec9dfa750,
title = "Coronary artery bypass in patients with type 2 diabetes: Experience from the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial",
abstract = "Objective: Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) was a study ofmanagement strategies for diabetic patients with myocardial ischemia and coronary artery disease. In a 2 × 2 design, early revascularization versus medical management with or without late revascularization and insulin sensitization versus insulin provision were examined. No advantage for either strategy was seen, except in the group undergoing early coronary artery bypass grafting (CABG). In that group, a reduction in subsequent myocardial infarction was noted. The purpose of our report was to characterize the conduct and short-term outcomes for CABG that led to this result.Methods: Data from the BARI 2D CABG stratum were collected, including the baseline demographic and cardiovascular characteristics, technical details of the operation, and perioperative morbidity and mortality, and analyzed.Results: A total of 347 patients were studied. The average cardiac function was normal, and most had multivessel disease. Almost all had undergone CABG by way of a median sternotomy using an internal mammary artery, and one third were off pump. The perioperative morbidity and mortality were low and compared well with larger outcomes databases.Conclusions: BARI 2D showed that early CABG in patients with type 2 diabetes and myocardial ischemia and multivessel disease reduced the subsequent myocardial infarction rates. The present results have demonstrated that this was achieved using off-pump surgery in certain cases, standard myocardial protection, and routine use of the internal mammary artery or other arterial grafts.",
author = "Sako, {Edward Y.} and Brooks, {Maria Mori} and Hardison, {Regina M.} and Schaff, {Hartzell V} and Frye, {Robert L.}",
year = "2014",
month = "10",
day = "1",
doi = "10.1016/j.jtcvs.2013.11.038",
language = "English (US)",
volume = "148",
pages = "1268--1272",
journal = "Journal of Thoracic and Cardiovascular Surgery",
issn = "0022-5223",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Coronary artery bypass in patients with type 2 diabetes

T2 - Experience from the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial

AU - Sako, Edward Y.

AU - Brooks, Maria Mori

AU - Hardison, Regina M.

AU - Schaff, Hartzell V

AU - Frye, Robert L.

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Objective: Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) was a study ofmanagement strategies for diabetic patients with myocardial ischemia and coronary artery disease. In a 2 × 2 design, early revascularization versus medical management with or without late revascularization and insulin sensitization versus insulin provision were examined. No advantage for either strategy was seen, except in the group undergoing early coronary artery bypass grafting (CABG). In that group, a reduction in subsequent myocardial infarction was noted. The purpose of our report was to characterize the conduct and short-term outcomes for CABG that led to this result.Methods: Data from the BARI 2D CABG stratum were collected, including the baseline demographic and cardiovascular characteristics, technical details of the operation, and perioperative morbidity and mortality, and analyzed.Results: A total of 347 patients were studied. The average cardiac function was normal, and most had multivessel disease. Almost all had undergone CABG by way of a median sternotomy using an internal mammary artery, and one third were off pump. The perioperative morbidity and mortality were low and compared well with larger outcomes databases.Conclusions: BARI 2D showed that early CABG in patients with type 2 diabetes and myocardial ischemia and multivessel disease reduced the subsequent myocardial infarction rates. The present results have demonstrated that this was achieved using off-pump surgery in certain cases, standard myocardial protection, and routine use of the internal mammary artery or other arterial grafts.

AB - Objective: Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) was a study ofmanagement strategies for diabetic patients with myocardial ischemia and coronary artery disease. In a 2 × 2 design, early revascularization versus medical management with or without late revascularization and insulin sensitization versus insulin provision were examined. No advantage for either strategy was seen, except in the group undergoing early coronary artery bypass grafting (CABG). In that group, a reduction in subsequent myocardial infarction was noted. The purpose of our report was to characterize the conduct and short-term outcomes for CABG that led to this result.Methods: Data from the BARI 2D CABG stratum were collected, including the baseline demographic and cardiovascular characteristics, technical details of the operation, and perioperative morbidity and mortality, and analyzed.Results: A total of 347 patients were studied. The average cardiac function was normal, and most had multivessel disease. Almost all had undergone CABG by way of a median sternotomy using an internal mammary artery, and one third were off pump. The perioperative morbidity and mortality were low and compared well with larger outcomes databases.Conclusions: BARI 2D showed that early CABG in patients with type 2 diabetes and myocardial ischemia and multivessel disease reduced the subsequent myocardial infarction rates. The present results have demonstrated that this was achieved using off-pump surgery in certain cases, standard myocardial protection, and routine use of the internal mammary artery or other arterial grafts.

UR - http://www.scopus.com/inward/record.url?scp=84908241132&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908241132&partnerID=8YFLogxK

U2 - 10.1016/j.jtcvs.2013.11.038

DO - 10.1016/j.jtcvs.2013.11.038

M3 - Article

C2 - 24507404

AN - SCOPUS:84908241132

VL - 148

SP - 1268

EP - 1272

JO - Journal of Thoracic and Cardiovascular Surgery

JF - Journal of Thoracic and Cardiovascular Surgery

SN - 0022-5223

IS - 4

ER -